Member Info for Toyin

Hi belgrano

My reply was mainly the “deal achieved” quote which I think is wrong. The deal on the table was just for psoriasis, this deal is a whole different ballgame, it’s the whole pillar. Is 8 months enough from a standing start, I don’t know. Regarding the nothing in spring quote, do you honestly think the nomad would have allowed him to say what he said in the rns 31/8, not a chance.

I understand it’s been quiet and we all want some news, but to start with the “pork pies” theory is a bit much. Let’s wait for the rns and make a decision when we have all the facts.

Bel, that doesn't mean a deal has been achieved, it just means if he had done the distribution deals the multinationals would have walked away. He has decided to hold out for a much bigger deal for the whole Axis pillar with one of the multinationals, this takes time, you are doing a deal for products that haven't been developed yet. I would caution anyone thinking a deal is in the bag.

Investors are free to buy and sell as they wish, if they think the ceo is telling porky pies I would be exiting sharpish!

bel, what great deal has been achieved a while back?

Centamin, the plan is to do a B2B deal for the whole Axis pillar, but the company are hoping to keep the distribution rights for B2C in the UK indefinitely to help understand customer needs. We are not a B2C but covid didn't really give us any other option, at least we are generating revenue. Plus I dont think sending out emails is going to break the bank!

Yes, Clio I did.

anon, I'm a bit concerned at your level of research. Cath never said anything, It was SA. I have said the £1.2m was a mistake, but there are legitimate reasoning behind the decision, which I fully agree with. If you think it is "fatal" & "trust is gone" why are you still holding.

Anyway that is one mistake, you said "repeatedly proven wrong" so what are the others?

anon, I think it's unfair to say it's all jam tomorrow. We have axis sales, we are launching in Spain before y/e, sales are growing, we will have Croda revenue very soon, this is all jam today.

I dont understand how the company has been repeatedly proven wrong, as far as I am aware there was a mistake putting out the £1.2m, apart from that, I think the company has done extremely well. Please correct me if you disagree.

anon, Cath owns over 5m shares, SA came to the company and took a haircut on his salary, you need to look a bit deeper.

He could have done distribution deals worth circ £1.2m but held off (he would have got a big bonus), so sales could have been way ahead of where they are now, he's playing the long game. You are looking at just one revenue stream in one pillar which I think is a big mistake.

I think if you give it another six months we will be in a very different place, we have lots of news flow in the not to distant future. As mad as you are about mad's comment he is 100% correct in my view.

Clio, I fully understand your disappointment at the sales of axisbiotix. As has been said many times the £1.2m was a mistake, it should never have been put out. The landscape has changed and Stuart decided to change course, let’s not forget if Stuart had taken those deals he would be a lot wealthier now, but he didn’t, that takes integrity, bottle and belief. I don’t know if the rns will show sales have reached a level the company is happy with, what level will the company be happy with, who knows, I think you mean a level the market will be happy with. We are focusing on one product, in one pillar and this company is so much more. I would wager in two years Axisbiotix-ps will be one of our smallest revenue streams. I believe this is a coffee can stock and that takes time.

Clio, why are they struggling, we had distribution deals which we didn’t take so we can achieve a much bigger prize. What’s so difficult to understand. No findings Clio, just an observation.

Aquae, I don’t know what his order number is I haven’t asked.

Clio, there are plenty of breakthrough results on trustpilot. Why can’t we discuss other benefits or potential benefits. I can’t prove anything neither can Elric but it’s interesting conversation, don’t have a downer on it. I’ve just shown a mate Elrics results and he’s just took a subscription out, so it’s not all bad.

Clio, whilst his coat grew very quickly, that wasn't the amazing thing. He had five lumps removed from his head and within a week his wounds had healed, the vet said he'd never seen a dog heal that quick and its not like he's young, he's twelve.

Aquae, dont laugh but my dogs on it, it worked for him too. I'm not joking.

Aquae, I did ask the question and yes you are right he cut the questions dead. If you have another interview straight away, leave enough time to answer investors, very poor from soh.

Clio, desperate men can do mad things, if he needs the money, he needs the money. But if he does sell I think it would finish him as a credible ceo.

Aquae, I am not disagreeing with anything you say, but you are missing my point. Croda signed up to use our technology, how does anybody know what Sederma has found in the last three years. If you have access to a new technology which is better, you don’t keep using the old. Sederma are using our technology to make new ingredients, so of course all the credits will go to Sederma. That doesn’t mean they haven’t used our tech to get to the end ingredient.

The fact is nobody knows but it’s good to throw ideas around.

Aquae, I agree and I believe it will. You don’t build a dedicated €5 million vessel on a whim. I think investors need to start thinking technology rather than product.

Will post order number asap, Elric is paying for the next one.

Aquae, a lysate is a lysate.

Is it possible they have used our technology to develop a new product? For e.g. could they use our platform to develop an ingredient from, let’s say celery?

I’m not saying BBB is us but I am saying it is possible because it is an extract.

My next order is due on the 26th, would you like me to post my order number?

Ok nick, seeing as you won’t back up your comment, I will back up mine.

SkinBioTherapeutics uses lysates (extracts) of probiotic bacteria.

(We extract probiotic bacteria)

Under the terms of the agreement, SkinBioTherapeutics' proprietary SkinBiotix(TM) platform will be paired with Croda's expertise in the development and commercialisation of unique, sustainable, cosmetic ingredients, focusing specifically on the growing skincare actives market.

(Croda (Sederma) develop ingredients)

U.S. patent application number 17/496358 was filed with the patent office on 2022-03-03 for topical cosmetic treatment of skin and scalp and corresponding active ingredient based on an extract of apium graveolens. This patent application is currently assigned to Sederma. The applicant listed for this patent is Sederma. Invention is credited to Nicolas Barriere, Olga Gracioso, Thibault Marchand, Philippe Mondon, Caroline Ringenbach.

(extract of apium graveolens.)

So in summary:

1. Sbtx technology extracts probiotic bacteria.

2. The patent is for the extraction of apium graveolens.

3. apium graveolens is celery, which is a probiotic.

So Sederma has filed a patent for the extraction of a probiotic which is exactly what our technology does.

So I ask again, why does the evidence suggest it isn’t us?

Nick, you said the evidence suggests it’s not ours, so explain.

I have wheeled nobody in, I am more than capable of fighting my own corner. Over to you.